Tumor Boards

NTRK3 Fusion

April 2019:

CT abdomen and pelvis demonstrating recurrent disease in the left pelvis.

July 2019:

 

First post-operative CT abdomen and pelvis demonstrating rapid recurrence of disease in the left hemipelvis

September 2019:

 

CT abdomen and pelvis after three cycles of gemcitabine and docetaxel demonstrating continued disease progression

December 2019:

 

CT abdomen and pelvis after eight weeks of larotrectinib demonstrating continued disease progression